All data are based on the daily closing price as of December 24, 2024
a
Alfresa Holdings
2784.TSE
13.68 USD
-0.09
-0.65%
Overview
Last close
13.68 usd
Market cap
2.56B usd
52 week high
17.73 usd
52 week low
13.17 usd
Target price
14.63 usd
Valuation
P/E
13.145
Forward P/E
N/A
Price/Sales
0.1376
Price/Book Value
0.8166
Enterprise Value
1.43B usd
EV/Revenue
0.0777
EV/EBITDA
3.6416
Key financials
Revenue TTM
18.39B usd
Gross Profit TTM
1.22B usd
EBITDA TTM
329.23M usd
Earnings per Share
1.08 usd
Dividend
0.2 usd
Total assets
9.14B usd
Net debt
-1.18B usd
About
Alfresa Holdings Corporation, through its subsidiaries, engages in the manufacture, wholesale, marketing, and import/export of pharmaceuticals, diagnostic reagents, and medical devices/equipment in Japan and internationally. It is involved in the ethical pharmaceuticals wholesaling business that offers diagnostic reagents and medical devices/equipment to hospitals, clinics, and dispensing pharmacies. The company also engages in self-medication products wholesaling business that offers over-the-counter drugs, including health foods, supplements, and other products to drug stores and pharmacies. In addition, it manufactures and markets active pharmaceutical ingredients, pharmaceuticals, diagnostic reagents, and medical devices, as well as undertakes contract manufacturing of pharmaceuticals. Further, the company's medical-related business includes its dispensing pharmacy and other medical-related businesses. The company was incorporated in 2003 and is based in Tokyo, Japan.